5000PCL1000-PDA-ALN納米粒。ZS型電位儀測(cè)定納米粒的粒徑、粒度分布和表面電位;透射電鏡觀察形態(tài);考察其在不同介質(zhì)中的穩(wěn)定性、溶血性;考察ALN用量及鈣離子存在條件對(duì)新型納米粒吸附羥基磷灰石[(Ca10PO46(OH)2,HA]的影響;研究其體外抗4T1乳腺癌細(xì)胞活性。結(jié)果 成功制得PTX-PEG5000PCL1000-PDA-ALN納米粒,棒狀,粒徑為(178.5±2.3)nm,分散指數(shù)(PDI)值為0.213±0.06,Zeta電位為(20.12±2.45)mV;在5%葡萄糖、0.9%生理鹽水、血漿中基本穩(wěn)定;無(wú)溶血現(xiàn)象;隨著ALN用量增加,新型納米粒對(duì)HA吸附率增大,可達(dá)48.63%,游離鈣離子降低其對(duì)HA的吸附能力;MTT結(jié)果顯示,其對(duì)4T1乳腺癌細(xì)胞發(fā)揮顯著抑制作用。結(jié)論 制備的PTX-PEG5000PCL1000-PDA-ALN納米粒粒度分布均勻、穩(wěn)定性良好、不溶血;通過(guò)ALN與HA上的鈣離子相結(jié)合,親骨性良好;對(duì)4T1細(xì)胞發(fā)揮毒性作用。;Objective Based on the adhesion of dopamine derivatives, the surface modified paclitaxel (PTX) nanoparticles were constructed and connected with Allen sodium phosphate (ALN). The new nanoparticles were characterized and the toxic effects on 4T1 cells were observed. Methods PTX nanoparticles were prepared by solvent precipitation method. The nanoparticles were placed in 0.5 mg/mL dopamine hydrochloride Tris buffer salt solution to form polymeric dopamine (PDA) on the surface, and then combined with the pro osseous drug ALN to obtain novel PTX-PEG5 000PCL1 000-PDA-ALN nanoparticles. Dynamic light scattering and transmission electron microscopy were used to investigate the size and morphology of the new nanoparticle. The stability and hemolysis in different medium were studied. Investigated the effect of ALN dosage and calcium ion condition on the adsorption of novel nanoparticles on hydroxyapatite (Ca10PO4)6(OH)2, HA] and studied its antitumor activity on 4T1 breast cancer in vitro. Results Successfully prepared PTX-PEG5 000PCL1 000-PDA-ALN nanoparticles, rod diameter (178.5 ±2.3) nm, Zeta potential (-20.12 ±2.45) mV, basically stable in 5% glucose, 0.9% saline and plasma, and no hemolysis. In vitro experiment results showed that, with the increase of ALN dosage, the adsorption rate of the new nanoparticles on HA increased, up to 48.63%, and the free calcium ions reduced the adsorption capacity; In vitro cytotoxicity assay (MTT) results showed that, PTX-PEG5 000PCL1 000-PDA-ALN nanoparticles had a significant inhibitory effect on 4T1 breast cancer cells. Conclusion The prepared PTX-PEG5 000PCL1000-PDA-ALN nanoparticles have uniform particle size distribution, good stability and did not cause hemolysis; Moreover, they have good affinity to bone through ALN and calcium ions on HA, and play a toxic role in 4T1 cells."/>

醉酒后少妇被疯狂内射视频,一本色道久久综合一,在线天堂新版资源www在线下载,中文字幕乱人伦高清视频,中字幕视频在线永久在线观看免费

首頁(yè) > 過(guò)刊瀏覽>2017年第40卷第12期 >2017,40(12):1695-1700. DOI:10.7501/j.issn.1674-6376.2017.12.004
上一篇 | 下一篇

聚合多巴胺改性紫杉醇納米粒靶向治療乳腺癌骨轉(zhuǎn)移

Treatment of bone metastasis of breast cancer with polydopamine modified paclitaxel nanoparticles

發(fā)布日期:2018-01-16
您是第位訪問(wèn)者
藥物評(píng)價(jià)研究 ® 2025 版權(quán)所有
技術(shù)支持:北京勤云科技發(fā)展有限公司
津備案:津ICP備13000267號(hào) 互聯(lián)網(wǎng)藥品信息服務(wù)資格證書(shū)編號(hào):(津)-非經(jīng)營(yíng)性-2015-0031